Anaphylaxis
📧 Sign up to get email alerts when something new happens for Anaphylaxis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-04-30FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
FDA approved a supplemental application for AUVI-Q (epinephrine auto-injector) from Kaleo, Inc., likely reflecting labeling changes.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction
This clinical trial update outlines the Canadian Anaphylaxis Network study focused on predicting recurrence after emergency presentation for…
-
FDA approval · 2025-03-13FDA Approved: EPINEPHRINE — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an Epinephrine product under Fresenius Kabi USA, LLC's Original Application. This marks the product's clearance for marketi…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Registry for the Food Allergy Community
A registry study for the food allergy community is currently recruiting to collect information on food hypersensitivity and related conditio…
-
FDA approval · 2025-03-05FDA Approved: NEFFY — Supplemental Application (ARS Pharmaceuticals Operations, Inc.)
The FDA approved a supplemental application for NEFFY (epinephrine) from ARS Pharmaceuticals Operations, Inc. The approval updates the produ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-28FDA Approved: EPINEPHRINE — Original Application (Baxter Healthcare Corporation)
FDA approved the original application for epinephrine by Baxter Healthcare Corporation. Epinephrine is used in emergencies for severe allerg…
-
FDA approval · 2025-02-28FDA Approved: EPINEPHRINE — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for EPINEPHRINE from American Regent, Inc., indicating an approved change to the product's labeling …
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: EPAP, Interviewstudy
Clinical trial update for EPAP interview study sponsored by Charité University, Berlin, currently recruiting for food allergy and peanut all…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Inhibition of Anaphylaxis by Ibrutinib [Phase 2]
Phase 2 trial evaluating ibrutinib for inhibition of anaphylaxis in food allergy has completed, with results posted on 2025-01-17.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
A clinical trial update describing acquisition and long-term observation of patients with severe allergic reactions (anaphylaxis); the study…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants. [Phase 1]
Phase 1 study completed comparing inhaled DMC-IH1 with intramuscular epinephrine (EpiPen) in healthy male and female participants.
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis [Phase 1]
A Phase 1 clinical trial evaluating whether dexamethasone can prevent the second phase or biphasic reaction of anaphylaxis, with recruitment…
-
FDA approval · 2024-08-09FDA Approved: NEFFY — Original Application (ARS Pharmaceuticals Operations, Inc.)
The FDA approved NEFFY (epinephrine) from ARS Pharmaceuticals in an original application for the treatment of anaphylaxis.
-
EMA approval · 2024-06-28First nasal adrenaline spray for emergency treatment against allergic reactions
The European Medicines Agency approved the first nasal spray formulation of epinephrine for emergency treatment of allergic reactions, provi…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
A trial update describing the Acutelines biobank for acute and emergency medicine; recruitment is ongoing across multiple acute conditions.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Design, Implementation and Evaluation of the Guided Observer Role in Clinical Simulation [NA]
A completed clinical trial evaluating the design, implementation, and evaluation of a guided observer role in clinical simulation for anaphy…
-
FDA label_change · 2024-02-28FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)
FDA approved a supplemental labeling application for AUVI-Q (epinephrine auto-injector) submitted by Kaleo, Inc., resulting in updated produ…
-
FDA approval · 2023-12-28FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)
The FDA has approved a supplemental application for epinephrine filed by BPI Labs, LLC under the existing NDA. The approval authorizes chang…
-
FDA approval · 2023-10-19FDA Approved: ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for Adrenalin (epinephrine in sodium chloride) from Par Health USA, LLC, enabling continued mark…
-
FDA approval · 2023-05-12FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)
FDA approved a supplemental application for Epinephrine from BPI Labs, LLC. This marks an additional regulatory authorization for Epinephrin…
-
FDA approval · 2023-04-21FDA Approved: ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) — Original Application (Par Health USA, LLC)
FDA approves Adrenalin, a formulation of epinephrine in sodium chloride, under the original application submitted by Par Health USA, LLC. Th…
-
FDA approval · 2023-02-10FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for EPIPEN (epinephrine auto-injector) filed by Viatris Specialty LLC.
-
FDA approval · 2022-08-15FDA Approved: EPINEPHRINE — Original Application (International Medication Systems, Limited)
FDA approved a new epinephrine product under Original Application NDA211363 from International Medication Systems, Limited.
-
EMA withdrawal · 2022-05-20EMA Application withdrawn: Neffy (epinephrine) — Ars Pharmaceuticals Irl Limited
The EMA withdrew the application for Neffy (epinephrine) by Ars Pharmaceuticals Irl Limited.
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers [Phase 4]
Phase 4 trial update on pharmacokinetics of intramuscular adrenaline in food-allergic teenagers (anaphylaxis).